Financial Calendar

09 November 2022 Q3 2022 financial results
Past Events
10 August 2022 Canaccord Genuity 42nd Annual Growth Conference
Registration
https://wsw.com/webcast/canaccord76/register.aspx?conf=canaccord76&page=nyxh.br&url=https://wsw.com/webcast/canaccord76/nyxh.br/2994723
08 August 2022 Q2 and H1 2022 financial results
Webcast
https://edge.media-server.com/mmc/p/238ogkmt
08 June 2022 Annual shareholders’ meeting
10 May 2022 Q1 2022 financial results
Online
https://edge.media-server.com/mmc/p/tt7m3ut2
25 March 2022 FY 2021 financial results
Online
https://edge.media-server.com/mmc/p/8kqurr2q
31 August 2021 Interim Financial Report H1, 2021
09 June 2021 Annual Shareholders’ Meeting
09 April 2021 Full Year 2020 Financial and Operating Results
Upcoming Events

Financial Downloads

SEC Filings

Special Reports

Special auditor report – Articles 7:180 juncto 7:179 and 7:191 CCA (2021 Warrants plan)

Special Reports
Download (FR)

Special auditor report – Articles 7:179, 7:191 and 7:193 CCA (Nasdaq IPO)

Special Reports
Download (FR)

All rights reserved © 2021 Nyxoah SA. All content on this presentation, including the texts, trademarks, service marks, logos, illustrations, photos, graphics, design etc., are the property of Nyxoah SA. Nyxoah SA. owns all rights with respect to any of their trademarks, service marks, logos, and copyrighted works appearing on this presentation. Patented and design protected technology. Device not for sale in U.S. The Genio® system by Nyxoah is intended to be used for patients who suffer from moderate to severe Obstructive Sleep Apnea (AHI of 15 to 65), have not tolerated, failed or refused PAP therapy and are not significantly overweight. Reviewed and approved: February 2020

Privacy Notice
Cookie Policy
 Cookie Settings
bubble
bubble
bubble
bubble
bubble